|
KIF23 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.916570E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.442600E-01 |
| Normal-vs-Stage2 |
3.344400E-01 |
| Normal-vs-Stage3 |
1.295740E-02 |
| Normal-vs-Stage4 |
5.565600E-04 |
| Stage1-vs-Stage2 |
8.735200E-01 |
| Stage1-vs-Stage3 |
3.917600E-02 |
| Stage1-vs-Stage4 |
1.300390E-03 |
| Stage2-vs-Stage3 |
1.104780E-01 |
| Stage2-vs-Stage4 |
2.301800E-03 |
| Stage3-vs-Stage4 |
2.712300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.560460E-03 |
| Normal-vs-AfricanAmerican |
5.074600E-01 |
| Normal-vs-Asian |
1.885990E-01 |
| Caucasian-vs-AfricanAmerican |
8.594400E-02 |
| Caucasian-vs-Asian |
3.126200E-01 |
| AfricanAmerican-vs-Asian |
2.440200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.698160E-03 |
| Normal-vs-Female |
4.788200E-02 |
| Male-vs-Female |
1.355810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.838300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.721510E-02 |
| Normal-vs-Age(61-80Yrs) |
2.881400E-03 |
| Normal-vs-Age(81-100Yrs) |
8.116400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.198800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.981400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.159900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.259000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.466410E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.578300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.468600E-01 |
| Normal-vs-Grade 2 |
2.671400E-01 |
| Normal-vs-Grade 3 |
1.336350E-02 |
| Normal-vs-Grade 4 |
5.612600E-04 |
| Grade 1-vs-Grade 2 |
3.542400E-01 |
| Grade 1-vs-Grade 3 |
1.793540E-02 |
| Grade 1-vs-Grade 4 |
4.995200E-04 |
| Grade 2-vs-Grade 3 |
2.974300E-02 |
| Grade 2-vs-Grade 4 |
1.159310E-03 |
| Grade 3-vs-Grade 4 |
7.580600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.464200E-01 |
| Normal-vs-ccB subtype |
3.849300E-04 |
| ccA subtype-vs-ccB subtype |
3.63829999999732E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.864100E-03 |
| Normal-vs-N1 |
3.795400E-03 |
| N0-vs-N1 |
6.621000E-03 |
|
|
